J Halper

Author PubWeight™ 38.57‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Disease modifying therapies in multiple sclerosis: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology and the MS Council for Clinical Practice Guidelines. Neurology 2002 4.27
2 Fatigue therapy in multiple sclerosis: results of a double-blind, randomized, parallel trial of amantadine, pemoline, and placebo. Neurology 1995 2.90
3 Expression of Ia-like antigen molecules on human granulocytes during early phases of differentiation. Proc Natl Acad Sci U S A 1977 2.80
4 Studies with B-cell allo- and hetero-antisera: parallel reactivity and special properties. Scand J Immunol 1976 2.74
5 Cellular localization of gene expression for progranulin. J Histochem Cytochem 2000 2.38
6 Efficacy of treatment of MS with IFNbeta-1b or glatiramer acetate by monthly brain MRI in the BECOME study. Neurology 2009 2.36
7 Patterns of expression of human "Ia-like" antigens during the terminal stages of B cell development. J Immunol 1978 1.76
8 Tendon proteoglycans: biochemistry and function. J Musculoskelet Neuronal Interact 2005 1.45
9 Effects of lysozyme on normal and transformed mammalian cells. Nature 1973 1.33
10 Meningio-angiomatosis: a report of six cases with special reference to the occurrence of neurofibrillary tangles. J Neuropathol Exp Neurol 1986 1.18
11 Transforming growth factors in solid human malignant neoplasms. Cancer Res 1983 1.10
12 Helplessness, self-efficacy, cognitive distortions, and depression in multiple sclerosis and spinal cord injury. Ann Behav Med 1997 1.04
13 Epithelial tissue-derived growth factor-like polypeptides. Cancer Res 1983 0.97
14 The effect of enrofloxacin on cell proliferation and proteoglycans in horse tendon cells. Cell Biol Toxicol 2004 0.88
15 Electrophysiological subtypes of psychotic states. Acta Psychiatr Scand 2007 0.86
16 Contrasting patterns of newer histocompatibility determinants in patients with rheumatoid arthritis and systemic lupus erythematosus. Arthritis Rheum 1978 0.84
17 Transforming growth factor e: amino acid analysis and partial amino acid sequence. Growth Factors 1992 0.81
18 Purification and characterization of a novel transforming growth factor. Cancer Res 1987 0.81
19 Naturopaths and childhood immunizations: heterodoxy among the unorthodox. Pediatrics 1981 0.80
20 Invasive disease caused by Trichosporon beigelii. Mayo Clin Proc 1983 0.80
21 Effects of immobilization on the biomechanical properties of the broiler tibia and gastrocnemius tendon. Poult Sci 2007 0.79
22 The interaction of IgE with rat basophilic leukemia cells--VI. Inhibition by IgGa immune complexes. Immunochemistry 1976 0.79
23 Adherence to disease-modifying therapy in multiple sclerosis: Part I. Rehabil Nurs 2002 0.79
24 Expression of growth factors in chicken growth plate with special reference to tibial dyschondroplasia. J Comp Pathol 1997 0.78
25 Neuroendocrine and behavioral responses to challenge with the indirect serotonin agonist dl-fenfluramine in adults with obsessive-compulsive disorder. Biol Psychiatry 1992 0.77
26 Identification of a membrane-associated receptor for transforming growth factor type E. J Recept Signal Transduct Res 1995 0.77
27 Adherence to disease-modifying therapy in multiple sclerosis: Part II. Rehabil Nurs 2002 0.77
28 Spontaneous in vitro differentiation of antigen-specific lymphocytes from a patient with immunoglobulin M gammopathy. J Clin Invest 1982 0.75
29 The broad impact of MS. Eur J Neurol 2009 0.75
30 Purification of epithelial-type transforming growth factor by micro-preparative electrophoresis chromatography. Biotechniques 1993 0.75
31 Transforming growth factor type e is a novel mediator of wound repair. Wound Repair Regen 2006 0.75
32 The skin and T-cell differentiation. N Engl J Med 1980 0.75
33 Primary arteriopathy in Takayasu's disease. Arch Pathol Lab Med 1984 0.75
34 Mitogenic effects of transforming growth factor type e on epithelial and fibroblastic cells--comparison with other growth factors. Exp Cell Res 1990 0.75
35 Purification of transforming growth factor type e. J Cell Biochem 1990 0.75
36 Coronary lesions in neurofibromatosis associated with vasospasm and myocardial infarction. Am Heart J 1984 0.75
37 The functional model in multiple sclerosis. Rehabil Nurs 1990 0.75
38 A comparative study of impairment ratings in multiple sclerosis patients. Rehabil Nurs 1988 0.75
39 Diagnosis of "myxedema madness". Am J Psychiatry 1985 0.75
40 Multiple sclerosis and self-help: new roles for nursing. J Community Health Nurs 1984 0.75